Carlo Honrado, MD
Facial Plastic Surgery · Los Angeles, CANPI 1437265980
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations.
Across 78 payments — averaging $27.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$349
- Stryker$346
- Revance Therapeutics, Inc.$336
- AbbVie$286
- Merz North America, Inc.$231
- Intersect ENT, Inc.$128
- plus $505 from 10 others
What the payments were for
- Food & beverage$2,181100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 20 | $349 |
| Stryker | 9 | $346 |
| Revance Therapeutics, Inc. | 3 | $336 |
| AbbVie(2 entities) | 13 | $286 |
| Merz North America, Inc. | 9 | $231 |
| Intersect ENT, Inc. | 3 | $128 |
| Vertex | 4 | $125 |
| Galderma Laboratories, L.p. | 4 | $88 |
| Smith+Nephew | 4 | $66 |
| Medtronic | 2 | $65 |
| Acclarent, Inc | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Neurent Medical Limited | 1 | $24 |
| Baudax Bio Inc. | 1 | $22 |
| GSK | 1 | $21 |
| Hikma Pharmaceuticals USA | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAXXIFY$250
How this compares
$2,181 in reported general payments places this provider in the 60th percentile of 120 facial plastic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 89 | $2,202 |
| Azelastine Hcl | 66 | $1,762 |
| Dexamethasone | 12 | $32 |
Paid to pharmacies, not to this prescriber.
Other facial plastic surgery in Los Angeles
- Kian KarimiLos Angeles$1.2M
- Geoffrey TrenkleLos Angeles$44K
- Behrooz TorkianLos Angeles$15K
- Amit KochharLos Angeles$4K
- Daniel SukatoLos Angeles$2K
- Anna HsuLos Angeles$2K
- Henry ChenLos Angeles$1K
- Steven LeeLos Angeles$1K
- Nicholas SchenckLos Angeles$1K
- Andrew ChoiLos Angeles$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.